Back to Search Start Over

Human organoids with an autologous tissue-resident immune compartment.

Authors :
Recaldin T
Steinacher L
Gjeta B
Harter MF
Adam L
Kromer K
Mendes MP
Bellavista M
Nikolaev M
Lazzaroni G
Krese R
Kilik U
Popovic D
Stoll B
Gerard R
Bscheider M
Bickle M
Cabon L
Camp JG
Gjorevski N
Source :
Nature [Nature] 2024 Sep; Vol. 633 (8028), pp. 165-173. Date of Electronic Publication: 2024 Aug 14.
Publication Year :
2024

Abstract

The intimate relationship between the epithelium and immune system is crucial for maintaining tissue homeostasis, with perturbations therein linked to autoimmune disease and cancer <superscript>1-3</superscript> . Whereas stem cell-derived organoids are powerful models of epithelial function <superscript>4</superscript> , they lack tissue-resident immune cells that are essential for capturing organ-level processes. We describe human intestinal immuno-organoids (IIOs), formed through self-organization of epithelial organoids and autologous tissue-resident memory T (T <subscript>RM</subscript> ) cells, a portion of which integrate within the epithelium and continuously survey the barrier. T <subscript>RM</subscript> cell migration and interaction with epithelial cells was orchestrated by T <subscript>RM</subscript> cell-enriched transcriptomic programs governing cell motility and adhesion. We combined IIOs and single-cell transcriptomics to investigate intestinal inflammation triggered by cancer-targeting biologics in patients. Inflammation was associated with the emergence of an activated population of CD8 <superscript>+</superscript> T cells that progressively acquired intraepithelial and cytotoxic features. The appearance of this effector population was preceded and potentiated by a T helper-1-like CD4 <superscript>+</superscript> population, which initially produced cytokines and subsequently became cytotoxic itself. As a system amenable to direct perturbation, IIOs allowed us to identify the Rho pathway as a new target for mitigation of immunotherapy-associated intestinal inflammation. Given that they recapitulate both the phenotypic outcomes and underlying interlineage immune interactions, IIOs can be used to study tissue-resident immune responses in the context of tumorigenesis and infectious and autoimmune diseases.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
1476-4687
Volume :
633
Issue :
8028
Database :
MEDLINE
Journal :
Nature
Publication Type :
Academic Journal
Accession number :
39143209
Full Text :
https://doi.org/10.1038/s41586-024-07791-5